Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Advent Capital Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Advent Capital Management
from 13F filings
Historical chart of Advent Capital Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Advent Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Advent Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $1.0M | 850k | 1.21 |
| 2024-06-30 | $32M | 29M | 1.08 |
| 2024-03-31 | $43M | 45M | 0.95 |
| 2023-12-31 | $54M | 55M | 0.99 |
| 2023-09-30 | $44M | 48M | 0.93 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1